Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Xiayuan Liang to Humans

This is a "connection" page, showing publications Xiayuan Liang has written about Humans.

 
Connection Strength
 
 
 
0.137
 
  1. Knez V, Bao L, Carstens B, Liang X. Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood. Leuk Lymphoma. 2020 09; 61(9):2129-2135.
    View in: PubMed
    Score: 0.020
  2. Wilberger AC, Liang X. Primary Nonanaplastic Peripheral Natural Killer/T-Cell Lymphoma in Pediatric Patients-An Unusual Distribution Pattern of Subtypes. Pediatr Dev Pathol. 2019 Mar-Apr; 22(2):128-136.
    View in: PubMed
    Score: 0.018
  3. Knez V, Liu X, Schowinsky J, Pan Z, Wang D, Lorsbach R, Lu C, Luedke C, Haag M, Carstens B, Swisshelm K, Yang LH, Jug R, Wang E, Liang X. Clinicopathologic and genetic spectrum of infantile B-lymphoblastic leukemia: a multi-institutional study. Leuk Lymphoma. 2019 04; 60(4):1006-1013.
    View in: PubMed
    Score: 0.017
  4. Liang X, Branchford B, Greffe B, McGavran L, Carstens B, Meltesen L, Albano EA, Quinones R, Cook B, Graham DK. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol. 2013 Jul; 35(5):e209-13.
    View in: PubMed
    Score: 0.012
  5. Liang X, Greffe B, Garrington T, Graham DK. Precursor natural killer cell leukemia. Pediatr Blood Cancer. 2008 Apr; 50(4):876-8.
    View in: PubMed
    Score: 0.008
  6. Gheorghe G, Albano EA, Porter CC, McGavran L, Wei Q, Meltesen L, Danielson SM, Liang X. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol. 2007 Feb; 29(2):112-6.
    View in: PubMed
    Score: 0.008
  7. Liu L, McGavran L, Lovell MA, Wei Q, Jamieson BA, Williams SA, Dirks NN, Danielson MS, Dubie LM, Liang X. Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia. Am J Clin Pathol. 2004 Jun; 121(6):810-5.
    View in: PubMed
    Score: 0.006
  8. Liang X, Meech SJ, Odom LF, Bitter MA, Ryder JW, Hunger SP, Lovell MA, Meltesen L, Wei Q, Williams SA, Hutchinson RN, McGavran L. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma. Am J Clin Pathol. 2004 Apr; 121(4):496-506.
    View in: PubMed
    Score: 0.006
  9. Liang X, Stork LC, Albano EA. Primary ocular adnexal lymphoma in pediatric patients: report of two cases and review of the literature. Pediatr Dev Pathol. 2003 Sep-Oct; 6(5):458-63.
    View in: PubMed
    Score: 0.006
  10. Liang X, Golitz LE, Smoller BR, Meech SJ, Odom LF, Williams SA, Ryder JW. Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma. Am J Clin Pathol. 2002 Feb; 117(2):276-82.
    View in: PubMed
    Score: 0.006
  11. Klein C, Kleinschmidt-DeMasters BK, Liang X, Stence N, Tuder RM, Moore BE. A Review of Neuropathological Features of Familial and Adult Hemophagocytic Lymphohistiocytosis. J Neuropathol Exp Neurol. 2019 03 01; 78(3):197-208.
    View in: PubMed
    Score: 0.004
  12. Sopfe J, Endres A, Campbell K, Hayes K, Trout AT, Liang X, Lorsbach R, O'Brien MM, Cost CR. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study. Pediatr Blood Cancer. 2019 05; 66(5):e27613.
    View in: PubMed
    Score: 0.004
  13. Yin L, Xu J, Li M, Reddy V, Zhou Q, Liu H, Chu P, Zhang Q, Huang Q, Gao Z, Liang X, Wang HY, Pan Z. Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers. Histopathology. 2016 Nov; 69(5):775-783.
    View in: PubMed
    Score: 0.004
  14. Salstrom JL, Kent M, Liang X, Wang M. Toddlers with anasarca and severe anemia: a lesson in preventive medicine. Curr Opin Pediatr. 2012 Feb; 24(1):129-33.
    View in: PubMed
    Score: 0.003
  15. Keating AK, Kim GK, Jones AE, Donson AM, Ware K, Mulcahy JM, Salzberg DB, Foreman NK, Liang X, Thorburn A, Graham DK. Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity. Mol Cancer Ther. 2010 May; 9(5):1298-307.
    View in: PubMed
    Score: 0.002
  16. Linger RM, DeRyckere D, Brand?o L, Sawczyn KK, Jacobsen KM, Liang X, Keating AK, Graham DK. Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood. 2009 Sep 24; 114(13):2678-87.
    View in: PubMed
    Score: 0.002
  17. Petersen WC, Schlis KD, Braverman RS, Carlson I, Liang X, Wang M. Pseudohypopyon: Extramedullary relapse of acute myelogenous leukemia with poor prognosis. Pediatr Blood Cancer. 2009 Jul; 52(7):885-7.
    View in: PubMed
    Score: 0.002
  18. Porter CC, Liang X, Gralla J, McGavran L, Albano EA. BCL6 expression correlates with monomorphic histology in children with posttransplantation lymphoproliferative disease. J Pediatr Hematol Oncol. 2008 Sep; 30(9):684-8.
    View in: PubMed
    Score: 0.002
  19. Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood. 2007 Feb 01; 109(3):1026-33.
    View in: PubMed
    Score: 0.002
  20. Graham DK, Salzberg DB, Kurtzberg J, Sather S, Matsushima GK, Keating AK, Liang X, Lovell MA, Williams SA, Dawson TL, Schell MJ, Anwar AA, Snodgrass HR, Earp HS. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. Clin Cancer Res. 2006 May 01; 12(9):2662-9.
    View in: PubMed
    Score: 0.002
  21. Graham DK, Liang X, Miller KL, Wei Q, Stork LC. Disseminated nasopharyngeal natural killer cell lymphoblastic lymphoma in a child. Med Pediatr Oncol. 2003 Apr; 40(4):251-3.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)